K
Katherine Marsden
Researcher at Royal Hobart Hospital
Publications - 55
Citations - 1236
Katherine Marsden is an academic researcher from Royal Hobart Hospital. The author has contributed to research in topics: Von Willebrand disease & Bone marrow. The author has an hindex of 21, co-authored 54 publications receiving 1137 citations. Previous affiliations of Katherine Marsden include University of Tasmania & Westmead Hospital.
Papers
More filters
Journal ArticleDOI
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.
Roslyn Bonar,Emmanuel J. Favaloro,Soma Mohammed,Monica Ahuja,Leonardo Pasalic,John Sioufi,Katherine Marsden +6 more
TL;DR: The influence of apixaban and rivaroxaban on haemostasis testing extends beyond routine coagulation assays to encompass a plethora of specialisedAssays, including factor assays, lupus inhibitor, and FVIII inhibitor estimation.
Journal ArticleDOI
Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring
Luke Bereznicki,Shane L Jackson,Gregory M. Peterson,EC Jeffrey,Katherine Marsden,David M. L. Jupe +5 more
TL;DR: In the hands of patients the CoaguChek XS showed good correlation with laboratory determination of INR and compared well with expanded and narrow clinical agreement criteria.
Journal ArticleDOI
Evaluating errors in the laboratory identification of von Willebrand disease in the real world.
Emmanuel J. Favaloro,Roslyn Bonar,Muriel Meiring,Elizabeth M. Duncan,Soma Mohammed,John Sioufi,Katherine Marsden +6 more
TL;DR: These findings explain the high rate of errors associated with VWD diagnosis and show different VWF assays and activity/antigen ratios show different utility in VWD and type identification.
Journal ArticleDOI
The effect of dabigatran on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples
Roslyn Bonar,Emmanuel J. Favaloro,Soma Mohammed,Leonardo Pasalic,John Sioufi,Katherine Marsden +5 more
TL;DR: Findings of haemostasis laboratory tests for one of the DOACs, dabigatran (Pradaxa), tested across a wide range of laboratory assays showed good reproducibility and concordance with expected drug levels assessed by mass spectrometry and were effective to quantify drug levels.
Journal ArticleDOI
Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage.
Elisabeth E Spurr,Nicole E Wiggins,Katherine Marsden,Katherine Marsden,Ray M. Lowenthal,Ray M. Lowenthal,SJ Ragg,SJ Ragg +7 more
TL;DR: It appears that HSC collections can remain adequate for safe transplantation after up to 14 years of cryostorage, and some precautions may be warranted, namely harvesting higher than normal numbers of HSCs in collections intended for long-term storage and repeating in vitro assays on harvests after long- term storage prior to transplantation.